We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

N/A
Product
Advertisement

SCF-c-Kit Signaling Axis: A Cancer Stemness Regulator

As a global leader in the recombinant technology, Sino Biological provides a diverse array of recombinant proteins, antibodies, and ELISA kits to facilitate research and development of cancer treatments that focus on c-Kit and other RTKs (EGFR, VEGFR, PDGFR, c-Met, TrkB, FGFR, and more).
Oncohost logo.
Product News

OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment

OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
The new M Bio building.
Product News

Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition

uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
T cells attacking a cancer cell.
Product News

Efficient Transduction of CAR Into T Cells

AMSBIO announce a new range of high-titer Chimeric Antigen Receptor (CAR) lentivirus that provide high transduction efficiency with long-term, stable expression in resting and actively dividing cells.
Diving Deep Into Cell Therapy: An Industry Perspective content piece image
Whitepaper

Diving Deep Into Cell Therapy: An Industry Perspective

Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
CAR T: A Promising Cell Therapy for Cancer Treatment content piece image
App Note / Case Study

CAR T: A Promising Cell Therapy for Cancer Treatment

CAR-T cell therapy has emerged as one of the most promising novel treatments in the fight against cancer.
The Certis logo
Product News

Certis Oncology Solutions Announces Three Abstracts Accepted for Presentation at AACR Annual Meeting

Certis Oncology Solutions has announced that three abstracts have been accepted for presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting.
The Cantargia logo.
Product News

Cantargia To host R&D Day on New Clinical Results of Nadunolimab in Pancreatic Cancer

Cantargia has announced it will host an R&D Day focusing on new clinical results and biomarker data for its lead asset, the IL1RAP-binding antibody nadunolimab, in pancreatic cancer patients.
The CureSearch logo
Product News

CureSearch To Fund Phase I Clinical Trial for Pediatric Brain Cancer

CureSearch for Children’s Cancer has announced that it will fund a Phase I clinical trial to bring new therapies to pediatric brain cancer patients, including those with limited or no treatment options.
The EpicentRx logo.
Product News

EpicentRx Receives Fast Track Designation From the U.S. FDA for Lead Asset

EpicentRx, Inc. has announced that the FDA has granted Fast Track Designation to RRx-001 for the prevention/attenuation of severe oral mucositis in chemotherapy and radiation-treated head & neck cancer patients.
Advertisement